Tag Archives: medical

Air New Zealand Requires Face Masks On All Flights | Instant News

Starting tomorrow, Air New Zealand will make face masks mandatory on all international flights to and from New Zealand as a result of the government’s updated overseas border requirements and as a further proactive security measure to prevent the spread of COVID-19.

Currently, customers traveling on domestic airlines, as well as between Australia, Rarotonga, Samoa, South Korea and Tonga are subject to local government requirements to wear masks on flights.

Air New Zealand Chief Operational Integrity and Safety Officer David Morgan said the airline was continuing to proactively review operational processes to keep customers, employees and New Zealand safe.

“As COVID-19 cases worldwide continue to increase, especially with new types of variants, we have implemented these requirements to further ensure the safety of our customers, aircraft crews and the wider New Zealand.

Our customers have been required by law to wear masks on flights to a number of our destinations, so extending this mandate across our network provides further protection against the potential spread of the virus. To date, our customers have been very supportive of the requirements for wearing masks and we are grateful for their continued cooperation. “

Air New Zealand continues to work with the New Zealand Government on border requirements, such as pre-departure testing announced last week. For the latest information, customers can check Air New Zealand
The COVID-19 Hub or the Government of New Zealand website.


© Scoop Media


image source

Cannabis Pet Business Launches First Natural Supplement | Instant News

Hale Animal Health has launched its first two premium pet supplement products as it continues its work to develop New Zealand’s first line of medicinal cannabis products for pets.

Partially owned by New Zealand’s largest medicinal cannabis company, Helius Therapeutics, Hale is a consumer brand that has been working on by Managing Director Leila de Koster since announcing the Helius partnership in May last year.

Leila de Koster – Managing Director of Hale Animal Health

“This is Hale – healthy and healthy! Our two Vitality Plus products for cats and dogs represent our first nutraceutical products. Vitality Plus is a premium oil blend designed to complement a pet’s basic diet and provide a balanced source of healthy fats and essential fatty acids. In the coming months, we will be releasing a range of natural supplements packed full of superfoods, with the aim of exporting as well, “he said.

Ms de Koster said the creation of the first set of CBD-based veterinary medicines approved in New Zealand remains absolutely critical to Hale’s overall strategy. In fact, Hale could be the first person to register an veterinary drug cannabis anywhere in the world.

At the same time, Helius is New Zealand’s first licensed marijuana producer to partner in the animal health category.

Developing a clinically proven cannabidiol (CBD) prescription product for pets, which veterinarians can confidently prescribe, is just as important for Helius Therapeutics. Based in Tamaki East Auckland, construction of Helius’ state-of-the-art manufacturing facility is nearing completion.

What’s more, the cannabis drug company brings its own animal health talent and experience. Helius’ New Chief Executive, Carmen Doran, runs Novartis Animal Health Operations in Scotland, while Head of Helius Quality, Bruce Wallace, was previously Global Head of Quality at Argenta.

The country’s new Medicinal Cannabis scheme allows local cannabis production. It also allows the development and delivery of health products and cannabis recipes for pets. Although a new concept in New Zealand, the sector is experiencing rapid growth globally, with significant domestic and export opportunities.

Ms de Koster said in order to get the first prescription of New Zealand’s medicinal cannabis product for animals, a lot of data will be collected, and clinical trials conducted, over the next two years. Hale will then present an extensive file of findings to ACVM (Agricultural Compounds and Veterinary Compounds) regulators in his bid for registration.

He said the barriers to people trying CBD products for their pets in the US include the fact that there is still little scientific research showing its efficacy and it is too difficult to measure the effectiveness of the products.

“Kiwi pet owners and veterinarians will likely have the same concerns. That’s why we provide solid evidence through clinical trials and registration processes for our CBD products in New Zealand, “he said.

The company’s first CBD products will be targeted at treating pain in dogs with osteoarthritis and future cannabis-based products could include cannabinoid chews to help with anxiety, and shampoos and conditioners to help treat skin conditions.

Meanwhile, Hale’s newly launched Vitality Plus product products for cats and dogs will be available at specialty pet stores and veterinary clinics across New Zealand. Liquid supplements, designed to complement basic pet diets, include cold-pressed flaxseed oil, cold-pressed extra virgin olive oil, sustainably sourced tuna oil, green shell shellfish oil and vitamin E as antioxidants.

Hale Animal Health has launched its first Vitality Plus product

In the coming months, Hale will then release the first round of its Best Life series which includes supplements tailored to the pet’s life stage, full of nutrients and superfoods. The first two products in this range are for adult and senior cats and dogs, with supplements for active puppies, kittens, and dogs to follow.

All ingredients have been carefully selected for their proven health benefits for pets and are undergoing a thorough research and development process to ensure a premium, high quality product suitable for pets.

Hale and Helius believe that their common goal of providing therapeutic cannabis products and medicines will be a game-changer for many Kiwi pet owners, who are desperate to naturally alleviate the pain and suffering of their companions. CBD has been shown to be effective at treating pet anxiety, stress, nausea, skin conditions, arthritis, and seizures – among other conditions.

“The reason most cited by pet owners in the US and Canada for buying CBD for their pets is to help with back and joint pain. We recognize that this is one of the most common problems that pets face, and that is why our clinical trial will focus on treating pain in dogs with osteoarthritis, ”said Ms de Koster.

Home to at least 1.1 million dogs and 1.5 million cats, pet owners in New Zealand alone already spend $ 1.8 billion on pet products and services each year, and demand is increasingly shifting to natural health products.

Managing Director Hale said spending on pet products internationally was enjoying strong growth. According to a report recently published in the US, spending on pet products continues to break records year after year.

In fact, spending by US pet owners increased by more than $ 3 billion from 2017 to 2018 – an annual growth rate of 4.3% which is in line with New Zealand’s 4.5% annual growth rate.

“We are proud to be at the forefront of animal health. We are excited to be one of the first animal welfare companies in the world to conduct clinical trials and register CBD drugs for pets.

“Cannabis-focused products will follow, but a first is our range of premium pet supplements. We ask Kiwi pet owners to look for these new local brands and support us on this great journey to improve the lives of our animal friends, ”said Leila de Koster.


© Scoop Media


image source

Misplaced Attacks On New Zealand’s Response To Covid-19 | Instant News

Peter’s Covid dunne-over is misplaced

Former long-time minister, including association health, in both the National (notably) and Labor-led government, Peter Dunne has earned a deserved reputation for his measured and methodological approach to the problem. I experienced this personally over 40 years ago in student politics at the University of Canterbury. This included him becoming president of the student association and myself being the editor of the student newspaper that same year – what an exciting year! Despite being different political animals, we maintained friendly relations at times over the years.

Now outside Parliament Dunne has become a political commentator and columnist continuing his measured and methodological approach from a usually well-written right-wing perspective.

Fell Short

Unfortunately she has failed to live up to these standards with her latest online articles published at Newsroom.

Peter Dunne’s key argument is that there has been an unhealthy refusal in New Zealand to hear multiple voices about how to respond to the Covid-19 pandemic. Of course if there is rejection, it is not healthy. He attributed the country’s success to “… public fear, and skillful communication accompanied by luck.” This is the wrong place.

Of course there is public fear; it is an unprecedented threatening and highly contagious pandemic. Yes, there is expertise in communication. But communication is also based on the best available evidence and is communicated with empathy and simple language.

New Zealand has the advantage of geographic location, but our success in fighting the pandemic cannot be reduced to “sheer luck.” This will not prevent us from getting flooded with viruses and our rundown public hospitals will be overwhelmed if we don’t take the strategic direction we are taking. This is the greatest omission of Dunne’s expressive choice of words.

The importance of strategy

It’s fair to say New Zealand’s initial response was vague, but that’s because the Ministry of Health is faithfully following advice from the World Health Organization. This is understandable if there is no further search. However, WHO itself still doubts alternative strategies for elimination or mitigation (including suppression) of community transmission. In March, the global epicenter of the coronavirus has shifted to Europe largely through the mitigation route (trying to control but not eliminating). Unfortunately WHO is vulnerable to Eurocentrism.

Fortunately our epidemiologists are instead looking at Asia and in particular the success that China has achieved in its response – elimination. This allows them to provide good advice to the government including scenarios about mortality rates if we follow Europe. Look at the evidence (as of January 3) now on the effectiveness of alternative strategies.

WHO reports the cumulative death rates per one million are Europe – 631, the Western Pacific – 10 (including Asian countries bordering the Pacific Ocean such as China, Thailand and Vietnam), New Zealand – 5, and China – 3.Our results are not results of luck, skillful communication and public fear. That’s a good strategy.

Peter Dunne made too many subsequent admissions from the Prime Minister that he was far from confident at first that the elimination strategy would work. This is not surprising. It’s the kind of pandemic that hasn’t been experienced in a century. It never happened before. The only lessons available are the experiences of limited epidemics in Asia and China’s response after the Wuhan outbreak.

Looking at Asia (what to do) and Europe (what not to do), epidemiologists advising governments on elimination provide the best available empirical advice but even they can’t be completely sure it will work. What they do know is that the mitigation will likely be worse (and they are right).

Demonization didn’t help

Unfortunately Dunne’s keyboard later came under attack on accusative rhetoric at the expense of measured methodology. He referred to and referred to (Professors Baker, Wilson and Hendry and Dr Wiles) as a small “circle of academic experts” who had “ears” of government and media. This circle he said was “getting closer and less critical.” Alternative views cannot be seen.

What is overlooked in this apparent demonization is that this tiny circle lies within the mainstream of epidemiologists and other experts including the modern epidemiologist ‘grandfather’ of New Zealand Professor David Skeggs.

Opponents of contrast elimination strategies on the fringes. Of course they shouldn’t be ignored. But proportionality is required. So is the evidence. They began by advocating the Swedish road which was later discredited and the cumulative mortality rate was 864 compared to our 5.

Their economic doubts were expressed as if there were no government salary subsidies and other financial support for businesses. Evidence suggests that New Zealand’s economic performance is better than expected and better than if we followed mitigation or herd immunity. This opponent has not been “ranked by the favorite academic.” On the contrary, they have been refuted in a measured and methodical manner with evidence.

Ignoring facts

But Peter Dunne also ignores facts. Epidemiologists such as Baker and Wilson are critical of the implementation aspects of elimination, particularly in relation to delays in introducing full border testing (including in quarantine facilities), in testing critical workers at these facilities, and in introducing mandatory face masks. . Initial flaws in contact tracing can also be added to the list.

But they criticize in an evidence-based rather than dramatic way. When Professor Baker was asked by Radio New Zealand whether our border protection had failed, he deftly replied that there had been several “failures”. I can still vividly remember the almost uncontrollable outrage at the Ministry of Health Professor Skeggs on Radio New Zealand last year when commenting on one of these “failures”.

As recently as today Sunday Star Times it has been published a longer article assessing the government’s response to Covid-19. While broadly positive about his approach, Professor Baker is quoted as describing him as “sluggish”. If this wasn’t critical, my mind was confused about what it would be like if it was critical.

Stronger ground but

Peter Dunne raises several valid concerns. He criticized cabinet minister Megan Woods for saying last year that New Zealand would be “in the front line” for the Covid-19 vaccine. This assertion is premature, but not as dangerous as it implies, due to external factors beyond our control. We are definitely near the front of negotiating agreements with potential vaccine providers. This is positive.

But the complexity of the supply chain, the ability of small countries to compete with larger ones, given the ‘Big Pharma’ push to maximize profits, and other countries with greater demand will make deliveries difficult to predict. This is not an equal field of play.

Dunne was in a stronger position when he criticized the release of the Heather Simpson-Brian Roche damning report on the border management system following the Auckland lockdown in late December. This is a common technique of successive governance. I cannot see the political advantage of the government over this decision as they seek to reduce the role of the Ministry of Health and the greater exposure of the report will help this agenda. Rather than any sneaky motive, I suspect it is the result of an overconfident ‘half too smart’ mentality.

Peter Dunne’s allegation of “days of genuinely good behavior disguised as upbeat half truth” is a false description of the response to Covid-19. Rather, the strategic response has been very successful, but in these unprecedented times, there has been too much inaction.

© Scoop Media


image source

SKMT Karachi will be the most modern medical facility in the country: PM – Pakistan | Instant News

Published in 23 January 2021 16:08

SKMT Karachi will be the most modern medical facility in the country: PM

ISLAMABAD (Dunya News) – Prime Minister Imran Khan said that the Shaukat Khanum Memorial Trust (SKMT) cancer hospital in Karachi will be one of the most modern medical facilities in the country.

In a tweet, the Prime Minister expressed satisfaction that the construction work at SKMT Karachi was proceeding at an extremely fast pace.

“Work in the SKMT Karachi basement is proceeding at a good pace after a slowdown during the COVID crisis,” he tweeted.

Imran Khan also shared some photos of construction work.

“God willing, this will be the largest and most modern SKMT hospital in Pakistan,” he said.


image source

NZ Paying Soaring Gloves Prices For Frontline Workers | Instant News

Photo: Steve Ardagh

The world is facing a severe shortage of covid protective gloves and New Zealand is paying increasing glove prices to help front-of-life healthcare workers, said the world’s leading Kiwi glove expert.

California-based New Zealander Steve Ardagh, who owns glove company Eagle Protect, said the price of gloves was increasing every month but it would soon be a supply issue rather than a cost.

Gloves provide a protective barrier against pathogens for the wearer. If they are not intact or damaged, it is a risk of cross infection, he said.

“New Zealand is a very, very small glove user by world standards and the country is basically living in a bubble like the Truman Show compared to any other country in the world. But that doesn’t make him immune from the commercial realities of soaring prices and limited supply.

“Factory prices have increased by more than 300 percent since March 2020 and are steadily increasing by between 15 and 30 percent each month.”

A Health Ministry report said New Zealand imported $ 37 million worth of personal protective equipment (PPE) to deal with Covid last year which was never used because it did not meet safety standards.

Ardagh said New Zealand appeared ill-equipped for pandemic PPE requirements.

“Had they had supplies it would have been of better quality and bought at pre-pandemic levels. However, New Zealand has had to struggle to buy substandard quality products with prices soaring in early 2020 to compete with the rest of the world. “

Ardagh said there were many ‘bad actors’ now involved in the glove trade and middlemen with everything from used gloves repackaged and sold as medical to empty box containers sent to unwary buyers, and the possibility of NZ getting caught in the this. , leading to defective product purchases and wasted millions of dollars.

“The risk is that buyers in New Zealand will not be aware of procurement risks and potentially make poor product and / or vendor choices.

“The main factor at play here is that many users of disposable gloves see it as a pure commodity and all the same, rather than as a special protective item. Thus, they do not perform the necessary due diligence in product purchases or supplier choices.

“When covid hit last year, Kiwi companies and well-meaning individuals with no PPE experience sought products from dealers and profit-focused third parties. PPE may seem like an easy to get product to industry, but this is clearly not proven.

“There have been many stories of rejection and poor quality gloves being offered as medical grade gloves and shipped around the world.

“Manufacturers are under pressure to meet the increasing demand for disposable gloves and because there is very little control over the quality of the raw materials used to make gloves, it is very easy to change materials and add cheaper products, making gloves less expensive. or reject the quality and potential health risks.

“The exploitation of workers in glove manufacturing has also been reported consistently over the years, and the continued pressure to increase manufacturing has increased labor abuses significantly.

“Better PPE sourcing planning and inventory levels, with less focus on direct costs, will help NZ navigate next year to protect front-line workers.

“New Zealand has been seen internationally as an example of an iconic response to the pandemic – partly due to geographic isolation and partly because of its swift action and cooperative population.

“The cracks that have emerged since then are related to expired procurement policies based on requests for proposal thoughts.

“This policy has the potential to encourage low-quality products and an irresponsible attitude from PPE suppliers. There is no reward or incentive to own shares in New Zealand under the system, ”Ardagh said.

Eagle Protect operates in Christchurch and California.

© Scoop Media


image source